Innovative Medicine Backed by the Power of
BioXcel Therapeutics, Inc. is a
commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.
commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.
Innovative Medicine
Backed by the
Power of
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Innovative Medicine
Backed by the Power of
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Our Approach to Drug Development
- Optimizes R&D Economics
- Shortens Development Timelines
- Increases Probability of Success
AI-based Drug Development
Our neuroscience and immuno-oncology franchises utilize our AI
approach to drug identification and development
Neuroscience
Immuno-Oncology
Jun 17, 2022
Addressing Alzheimer Agitation With Phase 3 TRANQUILITY Program of BXCL501VIEW RELEASE
Jun 07, 2022
BioXcel Therapeutics to Participate at Two Upcoming Investor ConferencesVIEW RELEASE
Jun 06, 2022
Vimal Mehta Recognized for Leadership in New Haven Biz Power 25: Healthcare 2022 ListVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Jun 27, 2022 09:59 AM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
12.11
CHANGE
0 (0%)
